The hitchhikers guide to cancer stem cell theory: Markers, pathways and therapy

Cancer stem cell (CSC) biology is a rapidly developing field within cancer research. CSCs are postulated to be a unique cell population exclusively capable of infinite self renewal, multilineage differentiation and with ability to evade conventional cytotoxic cancer therapy. These traits distinguish CSCs from their more differentiated counterparts, which possess only limited or no potential for self renewal and tumor initiation. Therefore, CSCs would be the driving motor of malignant growth and therapy resistance. Accordingly, successful cancer treatment would need to eliminate this highly potent group of cells, since even small residual numbers would suffice to recapitulate the disease after therapy. Putative CSCs has been identified in a broad range of human malignancies and several cell surface markers have been associated with their stem cell phenotype. Despite all efforts, a pure CSC population has not been isolated and often in vitro clonogenic and in vivo tumorigenic potential is found in several cell populations with occasionally contradictory surface marker signatures. Here, we give a brief overview of recent advances in CSC theory, including the signaling pathways in CSCs that also appear crucial for stem cells homeostasis in normal tissues. We discuss evidence for the interaction of CSCs with the stromal tumor environment. Finally, we review the emerging potentially effective CSC‐targeted treatment strategies and their future role in therapy. © 2012 International Society for Advancement of Cytometry

[1]  L. Ricci-Vitiani,et al.  Targeting apoptosis pathways in cancer stem cells. , 2013, Cancer letters.

[2]  M. Miyazaki,et al.  Aldehyde dehydrogenase 1‐positive cells in axillary lymph node metastases after chemotherapy as a prognostic factor in patients with lymph node‐positive breast cancer , 2012, Cancer.

[3]  O. Gallo,et al.  Cancer stem cells hypothesis and stem cells in head and neck cancers. , 2012, Cancer treatment reviews.

[4]  M. Reedijk,et al.  Developmental pathways in breast cancer and breast tumor-initiating cells: therapeutic implications. , 2012, Cancer letters.

[5]  G van der Pluijm,et al.  The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation , 2012, Oncogene.

[6]  Yuri Kogan,et al.  Strategies for cancer stem cell elimination: insights from mathematical modeling. , 2012, Journal of theoretical biology.

[7]  P. Oliver,et al.  The impact of novel retinoids in combination with platinum chemotherapy on ovarian cancer stem cells. , 2012, Gynecologic oncology.

[8]  Martin Götte,et al.  Flow cytometry in cancer stem cell analysis and separation , 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[9]  J. Engh,et al.  CD90 is identified as a marker for cancer stem cells in high-grade gliomas using tissue microarrays. , 2012, Neurosurgery.

[10]  Lilya V. Matyunina,et al.  Isolation and characterization of stem-like cells from a human ovarian cancer cell line , 2012, Molecular and Cellular Biochemistry.

[11]  D. Nam,et al.  Trans-Differentiation of Neural Stem Cells: A Therapeutic Mechanism Against the Radiation Induced Brain Damage , 2012, PloS one.

[12]  J. Kopeček,et al.  Selective inhibitory effect of HPMA copolymer-cyclopamine conjugate on prostate cancer stem cells. , 2012, Biomaterials.

[13]  D. Horst,et al.  The expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an independent prognostic marker for low survival in colorectal tumors. , 2012, Experimental and molecular pathology.

[14]  Jan Greve,et al.  Automated identification of circulating tumor cells by image cytometry , 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[15]  J. Palazzo,et al.  Dysplastic lesions in inflammatory bowel disease show increased positivity for the stem cell marker aldehyde dehydrogenase. , 2012, Human pathology.

[16]  L. Ricci-Vitiani,et al.  Knockdown of Ubiquitin Ligases in Glioblastoma Cancer Stem Cells Leads to Cell Death and Differentiation , 2012, Journal of biomolecular screening.

[17]  D. Campana,et al.  A new method for high speed, sensitive detection of minimal residual disease , 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[18]  S. Mocellin,et al.  Prognostic Value of Putative Circulating Cancer Stem Cells in Patients Undergoing Hepatic Resection for Colorectal Liver Metastasis , 2012, Annals of Surgical Oncology.

[19]  D. Louis,et al.  Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cells. , 2012, Journal of the National Cancer Institute.

[20]  H. Ulrich,et al.  Neural differentiation of rat aorta pericyte cells , 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[21]  P. Rohrlich,et al.  CD304 is preferentially expressed on a subset of B‐lineage acute lymphoblastic leukemia and represents a novel marker for minimal residual disease detection by flow cytometry , 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[22]  A. Donnenberg,et al.  Pericytes: A universal adult tissue stem cell? , 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[23]  Richard J. Jones,et al.  Concise Review: Cancer Stem Cells and Minimal Residual Disease , 2012, Stem cells.

[24]  H. Abken,et al.  Regression of metastatic melanoma by targeting cancer stem cells , 2012, Oncotarget.

[25]  Tomáš Sieger,et al.  Detection and monitoring of normal and leukemic cell populations with hierarchical clustering of flow cytometry data , 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[26]  K. Machida,et al.  Pluripotency factor-mediated expression of the leptin receptor (OB-R) links obesity to oncogenesis through tumor-initiating stem cells , 2011, Proceedings of the National Academy of Sciences.

[27]  T. Stokke,et al.  Prostate Cancer Cell Lines under Hypoxia Exhibit Greater Stem-Like Properties , 2011, PloS one.

[28]  F. DiMeco,et al.  CD90 is Identified as a Candidate Marker for Cancer Stem Cells in Primary High-Grade Gliomas Using Tissue Microarrays* , 2011, Molecular & Cellular Proteomics.

[29]  G. Camussi,et al.  Differentiation therapy: targeting human renal cancer stem cells with interleukin 15. , 2011, Journal of the National Cancer Institute.

[30]  S. Cheung,et al.  Granulin-Epithelin Precursor Is an Oncofetal Protein Defining Hepatic Cancer Stem Cells , 2011, PloS one.

[31]  J. Gil-Ranedo,et al.  An Off-Target Nucleostemin RNAi Inhibits Growth in Human Glioblastoma-Derived Cancer Stem Cells , 2011, PloS one.

[32]  Hong Peng,et al.  Interactions between cancer stem cells and their niche govern metastatic colonization , 2011, Nature.

[33]  N. Nguyen,et al.  Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy , 2011, Journal of Translational Medicine.

[34]  T. Welling,et al.  c-Met is a marker of pancreatic cancer stem cells and therapeutic target. , 2011, Gastroenterology.

[35]  N. Sato,et al.  SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity , 2011, Laboratory Investigation.

[36]  Wei-ru Xu,et al.  Oxymatrine diminishes the side population and inhibits the expression of β-catenin in MCF-7 breast cancer cells , 2011, Medical oncology.

[37]  D. Dinh,et al.  Cord blood stem cells revert glioma stem cell EMT by down regulating transcriptional activation of Sox2 and Twist1 , 2011, Oncotarget.

[38]  M. Biffoni,et al.  Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy , 2011, Cell Death and Differentiation.

[39]  A. Rangarajan,et al.  A Monoclonal Antibody against Human Notch1 Ligand–Binding Domain Depletes Subpopulation of Putative Breast Cancer Stem–like Cells , 2011, Molecular Cancer Therapeutics.

[40]  S. Shankar,et al.  Hedgehog Signaling Antagonist GDC-0449 (Vismodegib) Inhibits Pancreatic Cancer Stem Cell Characteristics: Molecular Mechanisms , 2011, PloS one.

[41]  Manuel Hidalgo,et al.  Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy. , 2011, Cell stem cell.

[42]  P. Carmeliet,et al.  A vascular niche and a VEGF–Nrp1 loop regulate the initiation and stemness of skin tumours , 2011, Nature.

[43]  Pradeep S Rajendran,et al.  Single-cell dissection of transcriptional heterogeneity in human colon tumors , 2011, Nature Biotechnology.

[44]  C. Beier,et al.  Chemoresistance of glioblastoma cancer stem cells - much more complex than expected , 2011, Molecular Cancer.

[45]  S. Fan,et al.  Prediction of Posthepatectomy Recurrence of Hepatocellular Carcinoma by Circulating Cancer Stem Cells: A Prospective Study , 2011, Annals of surgery.

[46]  S. Morgan Can new optical techniques for in vivo imaging and flow cytometry of the microcirculation benefit sickle cell disease research? , 2011, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[47]  Axel Mosig,et al.  Circulation times of prostate cancer and hepatocellular carcinoma cells by in vivo flow cytometry , 2011, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[48]  Hiroshi Iwasaki,et al.  CD133+ Cancer Stem Cell–like Cells Derived from Uterine Carcinosarcoma (Malignant Mixed Müllerian Tumor) , 2011, Stem cells.

[49]  G. Pirozzi,et al.  3‐O‐methylfunicone, from Penicillium pinophilum, is a selective inhibitor of breast cancer stem cells , 2011, Cell proliferation.

[50]  R. McLendon,et al.  Direct In Vivo Evidence for Tumor Propagation by Glioblastoma Cancer Stem Cells , 2011, PloS one.

[51]  Mauro Biffoni,et al.  Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells , 2011, Nature.

[52]  Daniel J. Hoeppner,et al.  Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions , 2011, Cell Death and Disease.

[53]  Huan Yang,et al.  Identification of CD44+CD24+ gastric cancer stem cells , 2011, Journal of Cancer Research and Clinical Oncology.

[54]  J. Petriz,et al.  ABCG2 is required to control the sonic hedgehog pathway in side population cells with stem‐like properties , 2011, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[55]  M. Salto‐Tellez,et al.  Sequential expression of putative stem cell markers in gastric carcinogenesis , 2011, British Journal of Cancer.

[56]  K. V. van Golen,et al.  Breast Cancer Stem Cells Survive Periods of Farnesyl-Transferase Inhibitor-Induced Dormancy by Undergoing Autophagy , 2011, Bone marrow research.

[57]  E. Dmitrovsky,et al.  Hedgehog-producing cancer cells respond to and require autocrine Hedgehog activity. , 2011, Cancer research.

[58]  Y. Ku,et al.  Hypoxia Induces Tumor Aggressiveness and the Expansion of CD133-Positive Cells in a Hypoxia-Inducible Factor-1α-Dependent Manner in Pancreatic Cancer Cells , 2011, Pathobiology.

[59]  T. Curran,et al.  The Hedgehog's tale: developing strategies for targeting cancer , 2011, Nature Reviews Cancer.

[60]  Stephen Gould,et al.  Canonical hedgehog signaling augments tumor angiogenesis by induction of VEGF-A in stromal perivascular cells , 2011, Proceedings of the National Academy of Sciences.

[61]  J. Rich,et al.  Deadly teamwork: neural cancer stem cells and the tumor microenvironment. , 2011, Cell stem cell.

[62]  Mitsuru Sasako,et al.  Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  J. Troge,et al.  Tumour evolution inferred by single-cell sequencing , 2011, Nature.

[64]  H. Abken,et al.  The beating heart of melanomas: a minor subset of cancer cells sustains tumor growth , 2011, Oncotarget.

[65]  Mingli Liu,et al.  Role of Notch and its oncogenic signaling crosstalk in breast cancer. , 2011, Biochimica et biophysica acta.

[66]  J. Shen,et al.  NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation , 2011, Oncogene.

[67]  James R. Downing,et al.  Evolution of human BCR–ABL1 lymphoblastic leukaemia-initiating cells , 2011, Nature.

[68]  M. Takao,et al.  Enumeration, characterization, and collection of intact circulating tumor cells by cross contamination‐free flow cytometry , 2011, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[69]  H. Abken,et al.  Eradication of melanomas by targeted elimination of a minor subset of tumor cells , 2011, Proceedings of the National Academy of Sciences.

[70]  Z. Naito,et al.  Nestin in gastrointestinal and other cancers: effects on cells and tumor angiogenesis. , 2011, World journal of gastroenterology.

[71]  P. Vyas,et al.  Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia. , 2011, Cancer cell.

[72]  Rong Wang,et al.  Glioblastoma stem-like cells give rise to tumour endothelium , 2010, Nature.

[73]  Ying Lu,et al.  Selection of tumorigenic melanoma cells using ALDH. , 2010, The Journal of investigative dermatology.

[74]  S. Morrison,et al.  Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. , 2010, Cancer cell.

[75]  W. Gianni,et al.  Cancer stem cells and epithelial-mesenchymal transition: revisiting minimal residual disease. , 2010, Current cancer drug targets.

[76]  Robert M Hoffman,et al.  Advances in cellular, subcellular, and nanoscale imaging in vitro and in vivo , 2010, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[77]  R. Bjerkvig,et al.  Glioma cell populations grouped by different cell type markers drive brain tumor growth. , 2010, Cancer research.

[78]  T. Schumacher,et al.  Development of adoptive cell therapy for cancer: a clinical perspective. , 2010, Human gene therapy.

[79]  R. McLendon,et al.  Integrin alpha 6 regulates glioblastoma stem cells. , 2010, Cell stem cell.

[80]  M. Pasca di Magliano,et al.  Pancreatic Cancer and Hedgehog Pathway Signaling: New Insights , 2010, Pancreatology.

[81]  Z. Agur,et al.  Disruption of a Quorum Sensing mechanism triggers tumorigenesis: a simple discrete model corroborated by experiments in mammary cancer stem cells , 2010, Biology Direct.

[82]  Thijs J. Hagenbeek,et al.  Therapeutic antibody targeting of individual Notch receptors , 2010, Nature.

[83]  S. Vandenberg,et al.  A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. , 2010, Cancer cell.

[84]  M. Wolter,et al.  A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha. , 2010, Brain : a journal of neurology.

[85]  M. Krause,et al.  Cancer stem cells at the crossroads of current cancer therapy failures--radiation oncology perspective. , 2010, Seminars in cancer biology.

[86]  C. Iacobuzio-Donahue,et al.  Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma. , 2010, Journal of the National Cancer Institute.

[87]  Xin Li,et al.  Detection of circulating tumor cells in breast cancer patients utilizing multiparameter flow cytometry and assessment of the prognosis of patients in different CTCs levels , 2010, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[88]  A. Flesken-Nikitin,et al.  Mouse Models for Cancer Stem Cell Research , 2010, Toxicologic pathology.

[89]  Justin C. Grindley,et al.  Tumour-initiating cells: challenges and opportunities for anticancer drug discovery , 2009, Nature Reviews Drug Discovery.

[90]  L. Mariani,et al.  Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment , 2009, Proceedings of the National Academy of Sciences.

[91]  O. Er,et al.  Cancer Stem Cells in Solid Tumors , 2009, Oncology Research and Treatment.

[92]  S. Morrison,et al.  Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution , 2009, Cell.

[93]  J. D'haese,et al.  Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer. , 2009, Gastroenterology.

[94]  Yi-Wei Chen,et al.  Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. , 2009, Biochemical and biophysical research communications.

[95]  S. Rutella,et al.  Cells with Characteristics of Cancer Stem/Progenitor Cells Express the CD133 Antigen in Human Endometrial Tumors , 2009, Clinical Cancer Research.

[96]  David Allard,et al.  Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer , 2009, Science.

[97]  Hui Wang,et al.  Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. , 2009, Cancer cell.

[98]  T. Wang,et al.  Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44 , 2009, Stem cells.

[99]  G. Daley,et al.  Functional Evidence that the Self‐Renewal Gene NANOG Regulates Human Tumor Development , 2009, Stem cells.

[100]  Tao Zhang,et al.  Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. , 2009, Cancer research.

[101]  A. Krešo,et al.  Cancer stem cells in solid tumors: an overview. , 2009, Seminars in radiation oncology.

[102]  K. Camphausen,et al.  Physiologic Oxygen Concentration Enhances the Stem-Like Properties of CD133+ Human Glioblastoma Cells In vitro , 2009, Molecular Cancer Research.

[103]  H. Tian,et al.  Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis , 2009, Proceedings of the National Academy of Sciences.

[104]  M. Korc,et al.  Nestin expression correlates with nerve and retroperitoneal tissue invasion in pancreatic cancer. , 2009, Human pathology.

[105]  J. Marks,et al.  Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells , 2009, Oncogene.

[106]  G. Vereb,et al.  Die hard: Are cancer stem cells the Bruce Willises of tumor biology? , 2009, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[107]  Lei Du,et al.  CD44 is of Functional Importance for Colorectal Cancer Stem Cells , 2008, Clinical Cancer Research.

[108]  R. Richardson,et al.  Prominin1 marks intestinal stem cells that are susceptible to neoplastic transformation , 2008, Nature.

[109]  S. Morrison,et al.  Efficient tumor formation by single human melanoma cells , 2008, Nature.

[110]  G. Camussi,et al.  Identification of a tumor‐initiating stem cell population in human renal carcinomas , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[111]  J. Massagué,et al.  TGFβ in Cancer , 2008, Cell.

[112]  K. Chan,et al.  Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell Populations , 2008, Molecular Cancer Research.

[113]  Michael Morse,et al.  Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[114]  M. Clarke,et al.  Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy , 2008, PloS one.

[115]  Ian A. White,et al.  CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. , 2008, The Journal of clinical investigation.

[116]  Curt Balch,et al.  Identification and characterization of ovarian cancer-initiating cells from primary human tumors. , 2008, Cancer research.

[117]  K. Wong,et al.  Direct Orthotopic Transplantation of Fresh Surgical Specimen Preserves CD133+ Tumor Cells in Clinically Relevant Mouse Models of Medulloblastoma and Glioma , 2008, Stem cells.

[118]  E. Verwiel,et al.  Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis. , 2008, Cancer research.

[119]  Susan G Hilsenbeck,et al.  Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. , 2008, Journal of the National Cancer Institute.

[120]  Hua Tian,et al.  A paracrine requirement for hedgehog signalling in cancer , 2008, Nature.

[121]  M. Westphal,et al.  Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria , 2008, Oncogene.

[122]  P. Chambon,et al.  Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling , 2008, Nature.

[123]  S. Natsugoe,et al.  CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer , 2008, British Journal of Cancer.

[124]  S. Fan,et al.  Identification of local and circulating cancer stem cells in human liver cancer , 2008, Hepatology.

[125]  M. Biffoni,et al.  Identification and expansion of the tumorigenic lung cancer stem cell population , 2008, Cell Death and Differentiation.

[126]  Jian Wang,et al.  CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells , 2008, International journal of cancer.

[127]  Peter Canoll,et al.  Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas. , 2008, Neurosurgery.

[128]  C. D. Salcido,et al.  Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics , 2008, Breast Cancer Research.

[129]  Mohamed H. Sayegh,et al.  Identification of cells initiating human melanomas , 2008, Nature.

[130]  P. Lichter,et al.  Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients , 2008, Clinical Cancer Research.

[131]  D. Birnbaum,et al.  ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. , 2007, Cell stem cell.

[132]  M. Todaro,et al.  Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. , 2007, Cell Stem Cell.

[133]  Albert D Donnenberg,et al.  Tumorigenic stem and progenitor cells: implications for the therapeutic index of anti-cancer agents. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[134]  C. Heeschen,et al.  Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. , 2007, Cell stem cell.

[135]  M. Clarke,et al.  Cancer stem cells and tumor metastasis: first steps into uncharted territory. , 2007, Cell stem cell.

[136]  T. Strojnik,et al.  Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival. , 2007, Surgical neurology.

[137]  Aleksandar Dakic,et al.  Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells , 2007, Science.

[138]  S. Rutella,et al.  Expression of CD133-1 and CD133-2 in ovarian cancer , 2007, International Journal of Gynecologic Cancer.

[139]  Michael F. Clarke,et al.  Phenotypic characterization of human colorectal cancer stem cells , 2007, Proceedings of the National Academy of Sciences.

[140]  Alexander Brawanski,et al.  CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. , 2007, Cancer research.

[141]  I. Ng,et al.  Identification and characterization of tumorigenic liver cancer stem/progenitor cells. , 2007, Gastroenterology.

[142]  Jianren Gu,et al.  CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity , 2007, International journal of cancer.

[143]  H. Namba,et al.  Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively. , 2007, Endocrinology.

[144]  J. Aster,et al.  The multifaceted role of Notch in cancer. , 2007, Current opinion in genetics & development.

[145]  P. Sánchez,et al.  HEDGEHOG-GLI1 Signaling Regulates Human Glioma Growth, Cancer Stem Cell Self-Renewal, and Tumorigenicity , 2007, Current Biology.

[146]  I. Weissman,et al.  Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma , 2007, Proceedings of the National Academy of Sciences.

[147]  J. Dick,et al.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.

[148]  L. Ricci-Vitiani,et al.  Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.

[149]  R. A. Etten,et al.  Requirement for CD44 in homing and engraftment of BCR-ABL–expressing leukemic stem cells , 2006, Nature Medicine.

[150]  Harikrishna Nakshatri,et al.  CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis , 2006, Breast Cancer Research.

[151]  Irving L Weissman,et al.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. , 2006, Cancer research.

[152]  M. Wicha Cancer Stem Cells and Metastasis: Lethal Seeds , 2006, Clinical Cancer Research.

[153]  Peter T Masiakos,et al.  Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[154]  Brian Bierie,et al.  Tumour microenvironment: TGFβ: the molecular Jekyll and Hyde of cancer , 2006, Nature Reviews Cancer.

[155]  G. Dontu,et al.  Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. , 2006, Cancer research.

[156]  S. Morrison,et al.  Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells , 2006, Nature.

[157]  Linheng Li,et al.  Normal stem cells and cancer stem cells: the niche matters. , 2006, Cancer research.

[158]  R. Hill Identifying cancer stem cells in solid tumors: case not proven. , 2006, Cancer research.

[159]  N. Maitland,et al.  Prospective identification of tumorigenic prostate cancer stem cells. , 2005, Cancer research.

[160]  B. Petersen,et al.  AUTOIMMUNE PANCREATITIS: DIAGNOSIS USING HISTOLOGY, IMAGING, SEROLOGY, OTHER ORGAN INVOLVEMENT AND RESPONSE TO STEROIDS , 2005 .

[161]  D. Elder,et al.  A tumorigenic subpopulation with stem cell properties in melanomas. , 2005, Cancer research.

[162]  E. Fredlund,et al.  Hypoxia-induced dedifferentiation of tumor cells--a mechanism behind heterogeneity and aggressiveness of solid tumors. , 2005, Seminars in cell & developmental biology.

[163]  R. Schneider-Broussard,et al.  Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. , 2005, Cancer research.

[164]  Danila Coradini,et al.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. , 2005, Cancer research.

[165]  T. Jacks,et al.  Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer , 2005, Cell.

[166]  H. Clevers,et al.  Wnt signalling in stem cells and cancer , 2005, Nature.

[167]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[168]  F. Gage,et al.  Cell fusion-independent differentiation of neural stem cells to the endothelial lineage , 2004, Nature.

[169]  J. Dick,et al.  Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity , 2004, Nature Immunology.

[170]  I. Weissman,et al.  Therapeutic implications of cancer stem cells. , 2004, Current opinion in genetics & development.

[171]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[172]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[173]  J. Dick,et al.  High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase. , 1998, Blood.

[174]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[175]  J. Dick,et al.  Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis. , 1996, Blood.

[176]  M. Caligiuri,et al.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.

[177]  T. Lapidot,et al.  Leukemia in Chronic Phase Leukemic Hematopoietic Cells From Patients With Chronic Myeloid High Level Engraftment of NOD/SCID Mice by Primitive Normal and , 2014 .

[178]  R. Arceci,et al.  Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival , 2012 .

[179]  J. Burns,et al.  Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers. , 2011, American journal of cancer research.

[180]  J. Vieweg,et al.  E-cadherin plasticity in prostate cancer stem cell invasion. , 2011, American journal of cancer research.

[181]  Jian Tu,et al.  A higher number of circulating tumor cells (CTC) in peripheral blood indicates poor prognosis in prostate cancer patients--a meta-analysis. , 2011, Asian Pacific journal of cancer prevention : APJCP.

[182]  Harikrishna Nakshatri,et al.  Breast cancer stem cells and intrinsic subtypes: controversies rage on. , 2009, Current stem cell research & therapy.

[183]  Myriam Alcalay,et al.  Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells , 2009, Nature.

[184]  Tannishtha Reya,et al.  Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia , 2009, Nature.

[185]  J. Massagué,et al.  Beyond tumorigenesis: cancer stem cells in metastasis , 2007, Cell Research.

[186]  I. Bayazitov,et al.  A perivascular niche for brain tumor stem cells. , 2007, Cancer cell.